Michael Accardi, Associate Director Veterinary Safety Pharmacology, discusses how drug-induced seizure (DIS) liabilities pose a life-threatening risk both in drug development and to the general population, contributing to compound attrition and new‐onset non-epileptic seizures in patients, respectively.

Download the Poster